178 related articles for article (PubMed ID: 16482495)
1. Plasma cell tumour progression in iMycEmu gene-insertion mice.
Kim JS; Han SS; Park SS; McNeil N; Janz S
J Pathol; 2006 May; 209(1):44-55. PubMed ID: 16482495
[TBL] [Abstract][Full Text] [Related]
2. Insertion of Myc into Igh accelerates peritoneal plasmacytomas in mice.
Park SS; Shaffer AL; Kim JS; duBois W; Potter M; Staudt LM; Janz S
Cancer Res; 2005 Sep; 65(17):7644-52. PubMed ID: 16140930
[TBL] [Abstract][Full Text] [Related]
3. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
4. Extraosseous IL-6 transgenic mouse plasmacytoma sometimes lacks Myc-activating chromosomal translocation.
McNeil N; Kim JS; Ried T; Janz S
Genes Chromosomes Cancer; 2005 Jun; 43(2):137-46. PubMed ID: 15751044
[TBL] [Abstract][Full Text] [Related]
5. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations.
Silva S; Kovalchuk AL; Kim JS; Klein G; Janz S
Cancer Res; 2003 Dec; 63(24):8656-63. PubMed ID: 14695177
[TBL] [Abstract][Full Text] [Related]
6. Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)-carrying tumors prefer Igk-Myc inversions over translocations.
Silva S; Wiener F; Klein G; Janz S
Genes Chromosomes Cancer; 2005 Apr; 42(4):416-26. PubMed ID: 15645495
[TBL] [Abstract][Full Text] [Related]
7. Myc translocations in B cell and plasma cell neoplasms.
Janz S
DNA Repair (Amst); 2006 Sep; 5(9-10):1213-24. PubMed ID: 16815105
[TBL] [Abstract][Full Text] [Related]
8. CDDO-Imidazolide inhibits growth and survival of c-Myc-induced mouse B cell and plasma cell neoplasms.
Han SS; Peng L; Chung ST; DuBois W; Maeng SH; Shaffer AL; Sporn MB; Janz S
Mol Cancer; 2006 Jun; 5():22. PubMed ID: 16759389
[TBL] [Abstract][Full Text] [Related]
9. Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice.
Wang Y; Sugiyama H; Axelson H; Panda CK; Babonits M; Ma A; Steinberg JM; Alt FW; Klein G; Wiener F
Oncogene; 1992 Jun; 7(6):1241-7. PubMed ID: 1375720
[TBL] [Abstract][Full Text] [Related]
10. A new variant 15; 16 translocation in mouse plasmacytoma leads to the juxtaposition of c-myc and immunoglobulin lambda.
Axelson H; Panda CK; Silva S; Sugiyama H; Wiener F; Klein G; Sumegi J
Oncogene; 1991 Dec; 6(12):2263-70. PubMed ID: 1766673
[TBL] [Abstract][Full Text] [Related]
11. E mu/S mu transposition into Myc is sometimes a precursor for T(12;15) translocation in mouse B cells.
Kovalchuk AL; Kim JS; Janz S
Oncogene; 2003 May; 22(18):2842-50. PubMed ID: 12743607
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin/Myc recombinations in murine Peyer's patch follicles.
Müller JR; Mushinski EB; Williams JA; Hausner PF
Genes Chromosomes Cancer; 1997 Sep; 20(1):1-8. PubMed ID: 9290947
[TBL] [Abstract][Full Text] [Related]
13. Molecular and cytological features of the mouse B-cell lymphoma line iMycEmu-1.
Han SS; Shaffer AL; Peng L; Chung ST; Lim JH; Maeng S; Kim JS; McNeil N; Ried T; Staudt LM; Janz S
Mol Cancer; 2005 Nov; 4():40. PubMed ID: 16277667
[TBL] [Abstract][Full Text] [Related]
14. B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu).
Palomo C; Zou X; Nicholson IC; Bützler C; Brüggemann M
Cancer Res; 1999 Nov; 59(21):5625-8. PubMed ID: 10554044
[TBL] [Abstract][Full Text] [Related]
15. A novel c-myc-activating reciprocal T(12;15) chromosomal translocation juxtaposes S alpha to Pvt-1 in a mouse plasmacytoma.
Shaughnessy J; Wiener F; Huppi K; Mushinski JF; Potter M
Oncogene; 1994 Jan; 9(1):247-53. PubMed ID: 8302586
[TBL] [Abstract][Full Text] [Related]
16. Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells.
Qi CF; Zhou JX; Lee CH; Naghashfar Z; Xiang S; Kovalchuk AL; Fredrickson TN; Hartley JW; Roopenian DC; Davidson WF; Janz S; Morse HC
Cancer Res; 2007 Mar; 67(6):2439-47. PubMed ID: 17363561
[TBL] [Abstract][Full Text] [Related]
17. ABL-MYC retroviral infection elicits bone marrow plasma cell tumors in Bcl-X(L) transgenic mice.
Linden M; Kirchhof N; Kvitrud M; Van Ness B
Leuk Res; 2005 Apr; 29(4):435-44. PubMed ID: 15725478
[TBL] [Abstract][Full Text] [Related]
18. Retroviral enhancer insertion 5' of c-myc in two translocation-negative mouse plasmacytomas upregulates c-myc expression to different extents.
Shaughnessy JD; Owens JD; Wiener F; Hilbert DM; Huppi K; Potter M; Mushinski JF
Oncogene; 1993 Nov; 8(11):3111-21. PubMed ID: 8414513
[TBL] [Abstract][Full Text] [Related]
19. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas.
Bhatia K; Huppi K; Spangler G; Siwarski D; Iyer R; Magrath I
Nat Genet; 1993 Sep; 5(1):56-61. PubMed ID: 8220424
[TBL] [Abstract][Full Text] [Related]
20. Genetic recombinations between c-myc and Igh mu as precursors for recombinations between c-myc and Igh alpha in BALB/c plasmacytomas.
Janz S; Kovalchuk AL; Müller JR; Potter M
Curr Top Microbiol Immunol; 1997; 224():241-50. PubMed ID: 9308247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
